Persistent Asset Partners’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-303
Closed -$9.8K – 227
2025
Q1
$9.8K Hold
303
– – 0.01% 158
2024
Q4
$24.2K Buy
+303
New +$1.65K 0.02% 124

Other funds holding RLAY

Persistent Asset Partners's RLAY Position: Q3 2026 in Review

Persistent Asset Partners sold out of Relay Therapeutics (RLAY) in Q3 2026, closing a stake of 70,693 shares — an estimated $1.32M sold.

Persistent Asset Partners first reported a position in RLAY in Q4 2024 and held it in 6 quarters. The position peaked at $1.32M in Q2 2026. 261 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.

  • Persistent Asset Partners reported no remaining Relay Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Persistent Asset Partners sold 70,693 Relay Therapeutics shares in Q3 2026, an estimated $1.32M.
  • Persistent Asset Partners first reported a position in Relay Therapeutics in Q4 2024 and held it in 6 quarters.
  • Persistent Asset Partners's Relay Therapeutics position peaked at $1.32M in Q2 2026.
  • 261 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.

Based on Persistent Asset Partners's 13F filing for Q3 2026, filed 13 Nov 2026.